PATENT CLAIM ANALYSIS

Application Number: 16110778
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "461000"]

Abstract:
Compounds, methods, and compositions are provided for the treatment of cancer, neurological disorders, and fibrotic disorders. Specifically, the invention includes administering an effective amount of a compound of Formula I, II, or III, or a pharmaceutically acceptable composition, salt, isotopic analog, prodrug, or combination thereof, to a subject suffering from a cancer, neurological disorder, or fibrotic disorder.

Claim (Index 1):
A compound of Formula I(t):

Metadata:
- Claim Count in Document: 7.0
- Percentile: 96.0
- Lexical Diversity: 1.68182
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14229130', '15782535', '15162074', '13690920', '15800930']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8191890391151805
- 35 USC 102 Novelty (BERT): 0.5521312637630136
- Combined Prediction Score: 0.7924832615799638
- Mean Citation Score: 383.39583000000016
- Max Citation Score: 509.22375
- Similarity Product: 258.2061100642383

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test